FEM Life Management FEM Life Management
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode Clair
  • Fil d’actualités
  • Mine
    • Blogs
    • Mes produits
    • Offres
    • Emplois
    • Liste des catégories
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Reels
  • Blogs
  • Marketplace
  • Offres
  • Emplois
  • Courses
  • Forums
  • Messages from Danielle
  • Pinterest
  • FEM Life Merch
  • How To: Create Page
  • How to: Engage
  • Womens Shelters
Ritika Rathore
Ritika Rathore
Chronologie
Amis
Photos
Vidéos
Blogs
Stories
Pages
Groupes
Evènements
Rechercher

    Evidence-Based Risk Profiling for SEMA3A Pharmacological Inhibition Size, Share, Growth Factors, Competitive Landscape, with Regional Forecast to 2035

    Semaphorin 3A (SEMA3A) represents a compelling biological target implicated in axonal guidance, tumor angiogenesis, immune regulation, and tissue fibrogenesis. However, targeting secreted semaphorins presents distinct off-target toxicity, mechanism redundancy, and translational clinical trial risks. This case study details how an R&D strategy team executed an evidence-based risk profiling...
    Ritika Rathore
    2026-10-28 06:50:28
    Suite de l'agenda
Plus
© 2026 FEM Life Management French
English Spanish Arabic French Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Environ Conditions générale de vente Confidentialité Contactez nous Support Center Annuaire